This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Rolf M. Gunnar, MD; Henry S. Loeb, MD; Raymond J. Pietras, MD; John R. Tobin, Jr., MD

JAMA. 1967;202(13):1124-1128.

Abstract
Studies of clinical and hemodynamic changes in 13 patients with shock due to acute myocardial infarction were conducted. Both levarterenol (norepinephrine) bitartrate and isoproterenol hydrochloride were infused, and the clinical and hemodynamic effects were compared. Arterial pressure could be increased to nearly normal levels in all patients when levarterenol was infused, and this drug appeared to contribute to recovery in four patients. Adequate arterial pressure was obtained in only one patient during isoproterenol infusion, and clinical deterioration was coincident with the change from levarterenol to isoproterenol infusion in four patients. Increases in cardiac output occurred with both drugs, but was related to clinical improvement only when this increase was associated with an elevation in mean arterial pressure. Maintenance of an adequate arterial perfusion pressure is essential in treating shock due to acute myocardial infarction. In most patients, levarterenol is superior to isoproterenol in achieving this goal.

Author Affiliations
From the Hektoen Institute for Medical Research. Cook County Hospital, the Department of Medicine, University of Illinois College of Medicine (Drs. Gunnar. Loeb, and Pietras), and the Department of Medicine. Loyola University Stritch School of Medicine (Dr. Tobin). Chicago. Dr. Loeb is a research fellow of the Chicago Heart Association.

Footnotes
Reprint requests to 1835 W Harrison St, Chicago 60612 (Dr. Gunnar).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Circulatory Shock: Use of Sympathomimetic and Related Vasoactive Agents
Weil et al.
JAMA 1975;231:1280-1286.
ABSTRACT  

Pathophysiology and Therapy of the Shock of Myocardial Infarction
HADDY
ANN INTERN MED 1970;73:809-827.
ABSTRACT  

Hemodynamic Responses to Chlorpromazine in Patients in Shock
Loeb et al.
Arch Intern Med 1969;124:354-358.
ABSTRACT  

Isoproterenol for the Treatment of Circulatory Shock
WEIL and SHUBIN
ANN INTERN MED 1969;70:638-641.
ABSTRACT